Page last updated: 2024-10-23

bethanechol and Atrophy

bethanechol has been researched along with Atrophy in 1 studies

Bethanechol: A slowly hydrolyzing muscarinic agonist with no nicotinic effects. Bethanechol is generally used to increase smooth muscle tone, as in the GI tract following abdominal surgery or in urinary retention in the absence of obstruction. It may cause hypotension, HEART RATE changes, and BRONCHIAL SPASM.
bethanechol : The carbamic acid ester of 2-methylcholine. A slowly hydrolysed muscarinic agonist with no nicotinic effects, it is used as its chloride salt to increase smooth muscle tone, as in the gastrointestinal tract following abdominal surgery, treatment of gastro-oesophageal reflux disease, and as an alternative to catheterisation in the treatment of non-obstructive urinary retention.

Atrophy: Decrease in the size of a cell, tissue, organ, or multiple organs, associated with a variety of pathological conditions such as abnormal cellular changes, ischemia, malnutrition, or hormonal changes.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Silva, J1
Pinto, R1
Carvallho, T1
Coelho, A1
Avelino, A1
Dinis, P1
Cruz, F1

Other Studies

1 other study available for bethanechol and Atrophy

ArticleYear
Mechanisms of prostate atrophy after glandular botulinum neurotoxin type a injection: an experimental study in the rat.
    European urology, 2009, Volume: 56, Issue:1

    Topics: Animals; Atrophy; Bethanechol; Botulinum Toxins, Type A; Drug Agonism; Injections; Male; Neurotoxins

2009